http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007231017-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aac4a747e60a2949ac458ccdbb76fdea |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 |
| filingDate | 2007-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_306a212ff074458afe717a5b3d5e167d |
| publicationDate | 2007-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2007231017-A |
| titleOfInvention | Rapamycin analogs containing antioxidant moieties |
| abstract | There is a need for rapamycin analogs that have resistance to potentially enhanced oxidative power and better stability in formulations. Rapamycin analogs having antioxidant moieties, or pharmaceutically acceptable salts or prodrugs thereof, are immunomodulators and are useful in the treatment of restenosis, immune diseases and autoimmune diseases. In addition, a composition that suppresses cancer, fungal growth, restenosis, transplant tissue rejection, and immune and autoimmune diseases in mammals, and cancer, fungal growth, restenosis, transplanted tissue Methods of suppressing rejection and immune and autoimmune diseases are also disclosed. One particularly preferred application of rapamycin analogs containing this antioxidant moiety is in medical devices, where stability and resistance to oxidative processes are essential to the success of a rapamycin-containing compounding device. [Selection] Figure 2 |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015518869-A |
| priorityDate | 2006-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 94.